Evidence map›Paper›PMID 26696529›Full record

ArticleMedical microbiology and immunology2016

Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs.

Eveli Kallas, Kristi Huik, Silver Türk, Merit Pauskar, Ene-Ly Jõgeda, Marina Šunina, Tõnis Karki, Don Des Jarlais, Anneli Uusküla, Radko Avi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Medical microbiology and immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Eveli KallasDepartment of Microbiology, University of Tartu, Ravila 19, 50411, Tartu, Estonia. eveli.kallas@ut.ee.ORCID http://orcid.org/0000-0003-3735-928X
Kristi HuikDepartment of Microbiology, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
Silver TürkDepartment of Microbiology, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
Merit PauskarDepartment of Microbiology, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
Ene-Ly JõgedaDepartment of Microbiology, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
Marina ŠuninaDepartment of Immunology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
Tõnis KarkiDepartment of Microbiology, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
Don Des JarlaisBeth Israel Medical Centre, The Baron Edmond de Rothschild Chemical Dependency Institute, New York, NY, USA.
Anneli UuskülaDepartment of Public Health, University of Tartu, Tartu, Estonia.
Radko AviDepartment of Microbiology, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
Irja LutsarDepartment of Microbiology, University of Tartu, Ravila 19, 50411, Tartu, Estonia.
University of Tartu · EEMount Sinai Beth Israel · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Some individuals remain uninfected despite repeated exposure to HIV. This protection against HIV has been partly associated with altered T cell subset distributions and CCR5 expression levels. However, the majority of studies have been conducted in sexually exposed subjects. We aimed to assess whether HIV infection and intravenous drug use were associated with differences in CCR5 expression, immune activation on the CD4+ and CD8+ T cells and T cell distribution among Caucasian persons who inject drugs (PWIDs). Analyses of the data from 41 HIV-positive PWIDs, 47 HIV-exposed seronegative PWIDs (ESNs) and 47 age- and gender-matched HIV-negative non-drug users are presented. Of all of the study subjects, 111 (82 %) were male, and the median age was 29 years. T cell phenotyping was performed in peripheral blood mononuclear cells with multicolour flow cytometry using anti-CD3, CD4, CD8, CD45RA, CD45RO, HLA-DR and CCR5 antibodies. The ESNs exhibited greater levels of immune activation and higher percentages of CD4+ CD45RA+RO+ and CD8+ CD45RA+RO+ cells compared to the controls but not the HIV-positive people. The CCR5 expression on the CD4+ T cell subsets in the ESNs was lower than that in the controls but similar to that the HIV positives. The percentages of CCR5+ T cells were similar in all study groups and in most of the studied cell populations. Intravenous drug use was similarly associated with differences in T cell subset distributions and CCR5 expression among both the HIV-positive and HIV-negative PWIDs compared with the controls.

Indexed as

Environmental ExposureFemaleFlow CytometryHIV InfectionsHumansImmunophenotypingMaleReceptors, CCR5Substance Abuse, IntravenousT-Lymphocyte SubsetsCCR5 protein, humanReceptors, CCR5HIV susceptibilityIDUImmunological profileInflammationOpiatesT cell subset

Identifiers

PMID26696529
OpenAlexW2233416698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.